Skip to content
Screener

Price / earnings at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
32.1×
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
6.9×-11.0×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
3.7×
Mannkind logo
MannkindMNKD
56.4×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
105.5×

Other financials

Income statement

See full
Revenue$243.6M+55.4%
Gross profit$220.0M+59.2%
Operating income$27.2M+34.9%
Net income$25.4M+42.6%
EPS (diluted)$0.30+30.4%

Balance sheet

See full
Cash & equivalents$175.7M-8.5%
Total debt$8.9M-8.9%
Total equity$654.1M+32.1%
Total assets$896.1M+35.5%

Cash flow

See full
Operating cash flow$47.2M+68.0%
CapEx$663.0K+302%
Free cash flow$46.5M+66.6%

Valuation

See full
Market cap$5.97B+146%
Enterprise value$5.8B+159%
P/S7.1×+2.5×

Profitability

See full
Gross margin89.8%+3.9pp
Operating margin11.9%+11.1pp
Net margin9.6%+8.7pp
FCF margin21.7%+8.8pp

Returns & leverage

See full
Return on equity14%+13.0pp
Debt / equity0.0×
Current ratio3.9×+0.3×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

Based on the most recent quarter.

The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →

Filed
Jul 28, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087545

FAQ

What is Kiniksa Pharmaceuticals International, plc's price / earnings?
Kiniksa Pharmaceuticals International, plc (KNSA) reported price / earnings of 61× in Q2 2026.
How has Kiniksa Pharmaceuticals International, plc's price / earnings changed year-over-year?
Kiniksa Pharmaceuticals International, plc's price / earnings decreased by 86.2% year-over-year, from 442.7× to 61×.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's price / earnings?
Over 2 years (2022 to 2025), Kiniksa Pharmaceuticals International, plc's price / earnings has grown at a 205.4% compound annual growth rate (CAGR), from 5.7× to 53×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about Kiniksa Pharmaceuticals International, plc's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude